期刊文献+

胰岛素样生长因子-1抑制Aβ_(25-35)诱导的SH-SY5Y细胞凋亡 被引量:2

IGF-1 attenuates Aβ_(25-35)-induced apoptosis in SH-SY5Y cells
下载PDF
导出
摘要 目的:探讨胰岛素样生长因子-1(IGF-1)对β淀粉样蛋白25-35(beta-amyloid 25-35,Aβ25-35)诱导的神经母细胞瘤细胞(SH-SY5Y细胞)凋亡的影响。方法:以SH-SY5Y细胞系为研究对象,将其分为对照组、Aβ25-35组和IGF-1预处理组。利用Cell Counting Kit-8(CCK-8)试剂盒检测细胞活性;Annexin V-FITC/PI双染色法检测细胞凋亡率;Western blot检测Bcl-x L、Bax及cleaved caspase-3的表达。结果:Aβ25-35可降低SH-SY5Y细胞活性,诱导其发生细胞凋亡。IGF-1预处理组细胞活性增加,细胞凋亡率降低,伴有Bcl-x L表达增加、Bax表达降低及casapse-3活化减少。结论:IGF-1可通过上调Bcl-x L、下调Bax的表达,抑制casapse-3的活化,发挥抗Aβ25-35诱导的细胞凋亡作用。 Objective: To explore the protective effect of insulin-like growth factor-1 (1GF-1) on Aβ25-35-induced apop- tosis in SH-SYSY cells, nethods:SH-SYSY cells were treated with different concentration of Aβ25-35 and IGF-1. Cell via- bility was detected by CCK-8. Apoptosis was measured by Annexin V-FITC/PI staining. Expression of Bcl-xL,Bax and cleaved caspase-3 was determined by Western blot. Results:Aβ25-35 inhibited cell viability and induced apoptosis in SH- SY5Y cells. Pretreatment with IGF-1 could significantly revesed the cytotoxicity effect of Aβ25-35, and IGF-1 could in- crease the ratio of Bcl-xL/Bax and inhibit the activation of caspase-3. Conclusion:These results indicate that IGF-I pro- tect SH-SY5Y cell from apoptosis induced by Aβ25-35 through increase of Bcl-xL/Bax and inactivation of caspase-3.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2015年第5期639-644,共6页 Chinese Journal of Neuroanatomy
基金 上海市金山区卫计委青年项目(JSKJ-KTQN-2014-08)
关键词 胰岛素样生长因子-1 AΒ25-35 凋亡 BCL-X L BAX caspase-3 IGF-I Aβ25-35 apoptosis Bcl-xL Bax caspase-3
  • 相关文献

参考文献21

  • 1Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease [J]. Alzheimers Dement, 2007, 3:186-191.
  • 2Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer's disease : implications for prevention trials [ J]. Neu- ron, 2014, 84:608 - 622.
  • 3Braverman LE, Wolf PA, Vasan RS, et al. Insulin-like growth fac- tor-1 and risk of Alzheimer dementia and brain atrophy [ J]. Neu- rology, 2014, 82:1613-1619.
  • 4Carro E, Trejo JL, Gerber A, et al. Therapeutic actions of insulin- like growth factor 1 on APP/PS2 mice with severe brain amyloidosis [ J ]. Neurobiol Aging, 2006, 27 : 1250 - 1257.
  • 5Carro E, Trejo JL, Gomez-Isla T, et al. Serum insulin-like growth factor 1 regulates brain amyloid-beta levels [ J ]. Nat Med, 2002, 8 : 1390 - 1397.
  • 6Yang X, Wei A, Liu Y, et al. IGF-I protects retinal ganglion cells from hypoxia-induced apoptosis by activating the Erk-1/2 and Akt pathways [ J ]. Mol Vis, 2013,19 : 1901 - 1912.
  • 7Reiman EM. Alzheimer's disease and other dementias : advances in 2013 [J]. Lancet Neurol, 2014, 13:3 -5.
  • 8Cheng B, Gong H, Xiao H, et al. Inhibiting toxic aggregation of amyloidogenic proteins : a therapeutic strategy for protein misfolding diseases [ J]. Biochim Biophys Aeta, 2013, 1830:4860 -4871.
  • 9Torres-Aleman I. Towm'd a comprehensive neurobiology of IGF-I [J]. Dev Neurobiol, 2010, 70:384-396.
  • 10Steen E, Terry BM, Rivera E J, et al. Impaired insulin and insulin- like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes [ J ] ? J Alzheimers Dis, 2005, 7:63 - 80.

同被引文献14

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部